BIONTECH
BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.
BIONTECH
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Mainz, Rheinland-Pfalz, Germany
Country:
Germany
Website Url:
http://www.biontech.de
Total Employee:
1001+
Status:
Active
Contact:
+49 6131 90-840
Email Addresses:
[email protected]
Total Funding:
1.74 B USD
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Amazon Organization Schema IPv6 ReCAPTCHA JsDelivr Cloudflare JS US Privacy User Signal Mechanism
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-09 | PhagoMed | PhagoMed acquired by BioNTech | N/A |
| 2021-07-19 | Kite - TCR therapy | Kite - TCR therapy acquired by BioNTech | N/A |
| 2020-01-16 | Neon Therapeutics | Neon Therapeutics acquired by BioNTech | 67 M USD |
Investors List
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - BioNTech
Temasek Holdings
Temasek Holdings investment in Post-IPO Equity - BioNTech
European Investment Bank
European Investment Bank investment in Post-IPO Debt - BioNTech
European Investment Bank
European Investment Bank investment in Post-IPO Debt - BioNTech
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Venture Round - BioNTech
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - BioNTech
Platinum Asset Management
Platinum Asset Management investment in Series B - BioNTech
MiraeAsset Financial Group
MiraeAsset Financial Group investment in Series B - BioNTech
Jebsen Capital
Jebsen Capital investment in Series B - BioNTech
Invus
Invus investment in Series B - BioNTech
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-02 | MediGene | BioNTech investment in Post-IPO Equity - MediGene | 26 M EUR |
| 2022-01-25 | InstaDeep | BioNTech investment in Series B - InstaDeep | 100 M USD |
Official Site Inspections
http://www.biontech.de Semrush global rank: 291.45 K Semrush visits lastest month: 228.31 K
- Host name: a23-48-104-105.deploy.static.akamaitechnologies.com
- IP address: 23.48.104.105
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
